Seizalam
- Product NDC
- 11704-650
- 11-digit product format
- 117040650
- Labeler code
- 11704
- Product ID
- 11704-650_5b6fdc8f-162b-4873-a70e-2a674064dca7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- midazolam hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Meridian Medical Technologies LLC
- Application
- NDA209566
- Marketing category
- NDA
- Marketing start
- 2018-09-14
- Marketing end
- 0000-00-00
- Substance
- MIDAZOLAM HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11704-650 | SEIZALAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [MERIDIAN MEDICAL TECHNOLOGIES LLC
] | 12 | Legacy NDC | 20230129_cb2381bf-984a-48a8-95c0-3017c34cc170.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11704-650-10 | 11704065010 | 10 VIAL, GLASS in 1 CARTON (11704-650-10) > 10 mL in 1 VIAL, GLASS (11704-650-01) | 2018-09-14 | 0000-00-00 | No | No | Current |